1. Inflammatory bowel disease in Hermansky-Pudlak syndrome: a retrospective single-centre cohort study.
- Author
-
O'Brien KJ, Parisi X, Shelman NR, Merideth MA, Introne WJ, Heller T, Gahl WA, Malicdan MCV, and Gochuico BR
- Subjects
- Abdominal Pain etiology, Adolescent, Adult, Age of Onset, Child, Child, Preschool, Defecation, Female, Gastrointestinal Hemorrhage etiology, Genotype, Humans, Infant, Inflammatory Bowel Diseases genetics, Inflammatory Bowel Diseases pathology, Inflammatory Bowel Diseases therapy, Male, Middle Aged, Retrospective Studies, Young Adult, Hermanski-Pudlak Syndrome complications, Inflammatory Bowel Diseases complications
- Abstract
Background: Knowledge about inflammatory bowel disease (IBD) in patients with Hermansky-Pudlak syndrome (HPS), a rare autosomal recessive disorder characterized by defective biogenesis of lysosome-related organelles, could provide insights into IBD in general., Objective: To expand the understanding of IBD in patients with HPS., Methods: Retrospective review of records from patients with HPS evaluated at the National Institutes of Health Clinical Center from 1995 to 2019 was conducted. Clinical features of IBD, genotyping results and histologic findings of colectomy specimens were analysed., Results: IBD affected 37 (14.2%; 12 male, 25 female) of 261 patients with HPS. Median age of onset was 17 years; range was 1 to 52 years. The most common symptoms of HPS IBD were hematochezia, abdominal pain and loose stools. Fistulae or extra-intestinal manifestations developed in 30% or 22%, respectively. Genotyping showed that patients with biallelic variants in HPS1, HPS3, HPS4 or HPS6 were diagnosed with IBD. Six children had very early-onset IBD. Patients with HPS-3 had mild manifestations of IBD. Medical therapy and bowel resection were utilized to treat 73% and 35% of patients with HPS IBD, respectively; 7 of 13 patients receiving anti-tumor necrosis factor alpha therapy had prolonged clinical responses. Active cryptitis, chronic inflammatory changes, granulomas and ceroid lipofuscinosis were histopathologic findings in three colectomy specimens., Conclusions: IBD resembling Crohn's disease affects some patients with HPS; genetic heterogeneity is a feature of HPS IBD. HPS3 is a new gene associated with human IBD. Very early-onset IBD can develop in HPS., (© Published 2021. This article is a U.S. Government work and is in the public domain in the USA.)
- Published
- 2021
- Full Text
- View/download PDF